Home › Immunoblastic Lymphadenopathy › North Carolina › Durham
Immunoblastic Lymphadenopathy clinical trials in Durham, NC
4 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- North Carolina Cancer Hospital, Chapel Hill · 10 mi away
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi away
Registry of Older Patients With Cancer
RecruitingObservational study
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi away
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi away
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- St. Louis, MO3 studies
- Boston, MA3 studies
- Atlanta, GA3 studies
- Columbus, OH3 studies
- New Haven, CT3 studies
- Baldwin Park, CA3 studies
- Rochester, MN3 studies
- Edison, NJ3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)59 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.